More recently, Shah and colleagues derived a threshold of 5 ng/L for hs-cTnI based on a target 99.5 % NPV in a cohort of patients without myocardial necrosis on presentation for the outcome of type 1 MI or cardiac death within 30 days [30]. Here, TNNI3 is linked to Myocardial necrosis.